Selene K Roberts, Ioannis Galgadas, David T Clarke, Laura C Zanetti-Domingues, Francesco L Gervasio, Marisa L Martin-Fernandez
{"title":"“在细胞适应和耐药的背景下靶向非小细胞肺癌中的突变EGFR”[药物发现]的勘误表。今天30(7)(2025)104407]。","authors":"Selene K Roberts, Ioannis Galgadas, David T Clarke, Laura C Zanetti-Domingues, Francesco L Gervasio, Marisa L Martin-Fernandez","doi":"10.1016/j.drudis.2025.104426","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":" ","pages":"104426"},"PeriodicalIF":6.5000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to \\\"Targeting mutant EGFR in non-small cell lung cancer in the context of cell adaptation and resistance\\\" [Drug Discov. Today 30(7) (2025) 104407].\",\"authors\":\"Selene K Roberts, Ioannis Galgadas, David T Clarke, Laura C Zanetti-Domingues, Francesco L Gervasio, Marisa L Martin-Fernandez\",\"doi\":\"10.1016/j.drudis.2025.104426\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":301,\"journal\":{\"name\":\"Drug Discovery Today\",\"volume\":\" \",\"pages\":\"104426\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.drudis.2025.104426\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.drudis.2025.104426","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Corrigendum to "Targeting mutant EGFR in non-small cell lung cancer in the context of cell adaptation and resistance" [Drug Discov. Today 30(7) (2025) 104407].
期刊介绍:
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.